Repare Therapeutics Inc. - Common Shares (NQ:RPTX)
1.650
-0.040
(-2.37%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 14, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 3,077,558 |
| Open | 1.680 |
| Bid (Size) | 2.150 (300) |
| Ask (Size) | 2.160 (100) |
| Prev. Close | 1.690 |
| Today's Range | 1.650 - 1.718 |
| 52wk Range | 0.8900 - 4.069 |
| Shares Outstanding | 42,088,446 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Repare (RPTX) Q2 Loss Narrows 52% ↗
August 08, 2025
Tuesday's after hours session: top gainers and losers ↗
July 15, 2025
Repare Therapeutics Announces Leadership Transitions
March 31, 2025
Frequently Asked Questions
Is Repare Therapeutics Inc. - Common Shares publicly traded?
Yes, Repare Therapeutics Inc. - Common Shares is publicly traded.
What exchange does Repare Therapeutics Inc. - Common Shares trade on?
Repare Therapeutics Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Repare Therapeutics Inc. - Common Shares?
The ticker symbol for Repare Therapeutics Inc. - Common Shares is RPTX on the Nasdaq Stock Market
What is the current price of Repare Therapeutics Inc. - Common Shares?
The current price of Repare Therapeutics Inc. - Common Shares is 1.650
When was Repare Therapeutics Inc. - Common Shares last traded?
The last trade of Repare Therapeutics Inc. - Common Shares was at 11/14/25 04:00 PM ET
What is the market capitalization of Repare Therapeutics Inc. - Common Shares?
The market capitalization of Repare Therapeutics Inc. - Common Shares is 69.45M
How many shares of Repare Therapeutics Inc. - Common Shares are outstanding?
Repare Therapeutics Inc. - Common Shares has 69M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
